COVID-19 long-term consequences: rapidly progressing cor pulmonale and its relation to hypercoagulation
Keywords:
Cor pulmonale, COVID-19, Right ventricular hypertrophy, Echocardiography, Long-term consequences of COVID-19, HypercoagulationAbstract
Patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. we described the effects of systemic thrombolysis on acute cor pulmonale in a patient suffering from COVID-19 long-term consequences. We examined the correlation between the Rapidly progressing cor pulmonale and its relation to hypercoagulation in 45 post COVID-19 patients at Osh State University, utilizing laboratory characteristics, radiological studies, and other clinical markers. A negative moderate correlation between PTI% and PT sec, suggesting that as PTI% decreases, the PT sec increases, potentially signalling hypercoagulability and the correlation between these variables is statistically significant (p<0.05). Moreover, a positive moderate correlation between PTI% and fibrinogen, indicating that lower PTI% is associated with higher fibrinogen levels. This correlation was also statistically significant (p<0.05). The study underscores the multifaceted nature of long-term COVID-19 complications, emphasizing the need for comprehensive patient monitoring. The significant correlations involving PTI% could serve as valuable indicators for clinicians to assess the risk of hypercoagulation and inflammation in patients, potentially guiding more tailored and timely interventions. However, the predominance of insignificant correlations calls for cautious interpretation of the results. It suggests that while some relationships between these physiological parameters and long-term COVID-19 complications exist, they may not be straightforward or may be influenced by other factors not captured in this analysis. This highlights the importance of holistic patient assessment and the potential for individual variability in response to long-term COVID-19.
Downloads
References
1. Ronderos Botero DM, Omar AMS, Sun HK, Mantri N, Fortuzi K, Choi Y, et al. COVID-19 in the healthy patient population: demographic and clinical phenotypic characterization and predictors of in-hospital outcomes. Arterioscler Thromb Vasc Biol. 2020; 40: 2764-2775.
2. Li Y, Fang L, Zhu S, Xie Y, Wang B, He L, et al. Echocardiographic characteristics and outcome in patients with COVID-19 infection and underlying cardiovascular disease. Front Cardiovasc Med. 2021; 8: 642973.
3. Jardin F, Vieillard-Baron A. Acute cor pulmonale. Curr Opin Crit Care. 2009; 15: 67-70.
4. Biswas A. Preventing the development of acute cor pulmonale in patients with acute respiratory distress syndrome: the first step. Ann Transl Med. 2016; 4: 146.
5. Creel-Bulos C, Hockstein M, Amin N, Melhem S, Truong A, Sharifpour M. Acute cor pulmonale in critically Ill patients with Covid-19. N Engl J Med. 2020; 382: e70.
6. Sysol JR, Machado RF. Classification and pathophysiology of pulmonary hypertension. Contin Cardiol Educ. 2018; 4(1): 10.1002/cce2.71.
7. MRC Dyspnoea Scale | Primary Care Respiratory Society (pcrs-uk.org)
8. Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019; 53: 1801904.
9. Cacho A, Prakash R, Sarma R, Kaushik VS. Usefulness of two-dimensional echocardiography in diagnosing right ventricular hypertrophy. Chest. 1983; 84: 154-157.
10. Hillis GS, Bloomfield P. Basic transthoracic echocardiography. BMJ. 2005; 330: 1432-1436.
11. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imag. 2015; 16: 233-270.
12. Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020; 18: 1752-1755.
13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847.
14. Kruse JM, Magomedov A, Kurreck A, Münch FH, Koerner R, Kamhieh-Milz J, et al D. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care. 2020; 24: 676.
15. Prabhu MM, Palaian S, Ansari M. Safety profile of COVID-19 vaccines, preventive strategies, and patient management. Expert Rev Vaccines. 2022; 21: 1087-1095.
16. Rauch S, Regli IB, Clara A, Seraglio PM, Bock M, Poschenrieder F, Resch M. Right ventricular myopericarditis in COVID-19: a call for regular echocardiography. Minerva Anestesiol. 2020; 86: 1253-1254.
17. Ferrante G, Fazzari F, Cozzi O, Maurina M, Bragato R, D'Orazio F, et al. Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography. Cardiovasc Res. 2020; 116: 2239-2246.
18. Bazan IS, Fares WH. Hypercoagulability in pulmonary hypertension. Clin Chest Med. 2018; 39: 595-603.
19. Xu D, Hu YH, Gou X, Li FY, Yang XY, Li YM, Chen F. Oxidative stress and antioxidative therapy in pulmonary arterial hypertension. Molecules. 2022; 27: 3724.
20. Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021; 88: 15-27.
21. González C, Servera E, Ferris G, Blasco ML, Marín J. Risk factors of readmission in acute exacerbation of moderate-to-severe chronic obstructive pulmonary disease. Arch Bronconeumol. 2004; 40: 502-507.
22. Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes Metab Syndr. 2021; 15: 869-875.
23. Capotosto L, Nguyen BL, Ciardi MR, Mastroianni C, Vitarelli A. Heart, COVID-19, and echocardiography. Echocardiography. 2020; 37: 1454-1464.
24. Boccatonda A, D'Ardes D, Rossi I, Grignaschi A, Lanotte A, Cipollone F, et al. Platelet count in patients with SARS-CoV-2 infection: A prognostic factor in COVID-19. J Clin Med. 2022; 11: 4112.
25. Wang L, He WB, Yu XM, Hu DL, Jiang H. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. World J Clin Cases. 2020; 8: 4370-4379.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
